Cepacol
Cepacol is a South African over-the-counter consumer health brand owned by Adcock Ingram, selling throat lozenges, cough syrups, throat spray, medicated drinks, and effervescent tablets for cold, flu, and sore throat relief through major retailers nationwide.
- Company typePrivate
- Founded-
- HeadquartersMidrand, South Africa
- Headcount51–100
- GTM typeB2C
- OfferingHardware or Manufacturing
What Cepacol does
Cepacol is a South African over-the-counter consumer health brand owned by Adcock Ingram Limited (Reg. No. 1949/034385/06), a private pharmaceutical conglomerate headquartered in Bryanston with operational offices in Midrand. The company manufactures and sells a portfolio of throat, cough, cold, and flu remedies including throat lozenges (Regular, Honey & Lemon, Menthol, Blackcurrant flavours containing Cetylpyridinium Chloride), hot medicated drinks branded as Medsip (Paracetamol + Vitamin C in Ginger and Honey Lemon), two cough syrups (daytime and Plus night-time variants combining Ivy Leaf, Pelargonium, and Valerian), a multi-action throat spray, an antibacterial throat gargle, and a newly launched raspberry-flavoured effervescent tablet positioned for multi-symptom relief and immune support. All formulations are SAHPRA-registered and target adult and paediatric consumers (typically age 6+) seeking symptomatic relief from respiratory illnesses.
The business model is wholesale OTC retail: Cepacol generates one-time product-sale revenue by stocking SKUs through South Africa's major pharmacy chains (Dischem, Clicks), supermarkets (Checkers, Pick 'n Pay), and e-commerce marketplaces (Takealot). Distribution is single-country, with no disclosed export activity or international e-commerce operations. Consumer acquisition is driven by a combination of broad retail shelf presence, a content-marketing website (cepacol.co.za) with a symptom checker and educational blog, and a Facebook presence (@CepacolSA), positioning Cepacol as a household-name legacy brand within the South African cold and flu category.
At the corporate level, Cepacol operates as a brand within Adcock Ingram rather than a standalone legal entity, sharing parent-level manufacturing, regulatory affairs, and distribution infrastructure. Pricing is not publicly disclosed on the company website and product positioning targets the mass-market consumer tier. Recent strategic emphasis has been on line-extension (the August 2024 Effervescent launch and the cough syrup range), digital touchpoint investment, and retention of omnichannel shelf presence across all major South African retailers.
Cepacol firmographics
Firmographics- Name
- Cepacol
- Legal name
- Adcock Ingram Limited
- Website
- https://cepacol.co.za
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Cepacol is a South African over-the-counter consumer health brand owned by Adcock Ingram, selling throat lozenges, cough syrups, throat spray, medicated drinks, and effervescent tablets for cold, flu, and sore throat relief through major retailers nationwide.
- Ownership category
- akta.pro rank
Cepacol industry classification
Industry- Product category
- OTC Pharmaceuticals (Throat Care & Cold/Flu Remedies)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cold, Flu & Cough Remedies (HLAIADAB)
- akta.pro secondary industry
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where Cepacol is headquartered
LocationHeadquarters
- HQ city
- Midrand
- HQ country
- South Africa
- HQ region
- Africa
Offices1 record
Markets served
Cepacol business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel
Revenue model
- OTC Pharmaceutical Product Sales: Cepacol generates revenue through the sale of over-the-counter cold, cough, and flu remedy products through retail pharmacies and stores in South Africa. Products are sold as one-time purchases at various price points through major retailers.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels3 records
Cepacol product offering
Product offeringCore offering
Cepacol manufactures and sells an over-the-counter (OTC) range of throat care, cough, and cold/flu remedies for South African consumers. The product portfolio spans multiple delivery formats — antibacterial throat lozenges, throat spray, cough and cold syrups, hot medicated drinks (Medsip), effervescent tablets, and throat gargle — each formulated with active ingredients such as Cetylpyridinium Chloride, Ivy Leaf, Pelargonium sidoides, Menthol, Paracetamol, and supporting vitamins to deliver targeted symptom relief.
Product overview
Cepacol is a pharmaceutical brand by Adcock Ingram offering an over-the-counter range of cold, cough, and flu remedies. The portfolio includes throat lozenges (Regular, Honey & Lemon, Menthol, Blackcurrant flavours), hot medicated drinks (Medsip in Ginger and Honey Lemon), syrups (Cough & Cold Syrup and Plus Cough & Cold Syrup for night-time relief), throat spray, throat gargle, and effervescent tablets. All products target symptoms of sore throat, cough, cold, flu, and related respiratory conditions.
Differentiator
Problem solved
Functional benefit
Brands
- Cepacol Throat Lozenges: Antibacterial throat lozenges available in Regular, Honey & Lemon, Menthol, and Blackcurrant flavors. Contains Cetylpyridinium chloride for sore throat relief.
- Cepacol Cough & Cold Syrup
- Cepacol Plus Cough & Cold Syrup
- Cepacol Throat Spray
- Cepacol Medsip
- Cepacol Antibacterial Throat Gargle
- Cepacol Effervescent
Products and services
- Cepacol Throat Lozenges Antibacterial throat lozenges providing rapid relief of sore throats. Available in Regular, Honey and Lemon, Menthol, and Blackcurrant flavours. Contains Cetylpyridinium Chloride 1.47 mg and Benzyl alcohol 6.5 mg as active ingredients. For South African consumers seeking sore throat relief.
- Cepacol Cough & Cold Syrup Non-drowsy, alcohol-free multi-action syrup containing Ivy Leaf and Pelargonium. Provides targeted relief for cough, congestion, and sore throat with antibacterial and antiviral properties. Suitable from age 6. For South African consumers seeking daytime cold symptom relief.
- Cepacol Plus Cough & Cold Syrup Night-time cough and cold syrup combining Ivy Leaf, Pelargonium, and Valerian extract for cough relief and sleep support. Sugar and alcohol-free. Provides symptomatic relief from coughing, nasal congestion, sneezing and a runny nose. For South African consumers seeking night-time cough relief.
- Cepacol Throat Spray Multi-action throat spray with 4-in-1 formula combating sore throat and offering cough relief. Contains Ivy Leaf, Pelargonium, and Menthol. Sugar and alcohol-free with antibacterial and antiviral properties. For South African consumers seeking targeted sore throat and cough relief.
- Cepacol Medsip Hot medicated drink containing Paracetamol 800 mg, Caffeine 50 mg, and Ascorbic acid 10 mg per 5g sachet. Available in Honey Lemon and Ginger flavours. Provides relief from fever, headaches, sore throats, and minor aches and pains associated with colds and flu. For South African consumers seeking hot medicated pain and fever relief.
- Cepacol Effervescent Raspberry-flavoured effervescent tablet providing multi-symptom relief of cough, colds, and flu while supporting immune system. Contains Vitamin A, Vitamin D3, Ivy Leaf, African Geranium (Pelargonium), Zinc Citrate, and Vitamin C. Sugar-free, suitable from age 6. For South African consumers seeking multi-symptom cold and flu relief with immune support.
- Cepacol Antibacterial Throat Gargle Antibacterial throat gargle solution containing Cetylpyridinium Chloride 50 mg per 100 ml with Alcohol 15.8% v/v. For mouth and throat infections. For South African consumers seeking antiseptic mouth and throat care.
Quantifiable outcome
- Cepacol products are registered with SAHPRA (South African Health Products Regulatory Authority)
Companies that use Cepacol
Customer profileSegments1 record
Ideal customer profiles1 record
Cepacol technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cepacol partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights5 records
Cepacol competitors and assessment
Company assessmentDirect peers
- Difflam: Viatris/Mylan throat spray and lozenge range targeting sore throat and oral inflammation; directly comparable to Cepacol Throat Spray and Cepacol Antibacterial Throat Gargle in mechanism and use case.
- Strepsils: Reckitt's flagship throat lozenge brand competing directly with Cepacol Throat Lozenges in the antibacterial sore-throat segment across multiple markets including South Africa.
- Betadine: Mundipharma's antiseptic throat gargle and lozenge portfolio overlapping with Cepacol's antibacterial gargle and lozenge SKUs in the sore-throat and oral-infection category.
- ACC: Hexal/Sandoz acetylcysteine cough and cold brand, comparable in cold/flu symptom positioning and effervescent/tablet formats to Cepacol's expanded range including Effervescent.
- Prospan: Ivy-leaf-based cough syrup brand competing directly with Cepacol Cough & Cold Syrup and Cepacol Plus Cough & Cold Syrup on the same active botanical ingredient.
- Mucosolvan: Sanofi's ambroxol-based cough syrup competing with Cepacol Cough & Cold Syrup in the OTC cough-relief segment, including in South African pharmacy channels.
- Lemsip: Reckitt's hot medicated drink brand for cold and flu symptom relief, directly comparable to Cepacol Medsip (paracetamol + vitamin C sachets) in format and consumer use case.
Broad incumbents
- Vicks: Procter & Gamble's broad respiratory-care portfolio (VapoRub, syrups, lozenges) covering multiple cold/flu symptoms; competes with Cepacol across formats but as part of a much wider P&G portfolio.
Others
- Panado: Sibling Adcock Ingram OTC brand (paracetamol-based pain and fever relief); not a competitor in the sore-throat niche but a portfolio companion within the same Winter Warriors campaign.
Regional players
- Covonia: UK-focused cough and cold remedy brand with comparable OTC syrup and lozenge formats; relevant as a category reference point rather than a direct South African competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Cepacol social profiles
Digital presenceCepacol financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cepacol leadership team
Management profileNumber of profiles
Cepacol funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cepacol M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cepacol
What does Cepacol do?
Cepacol manufactures and sells an over-the-counter (OTC) range of throat care, cough, and cold/flu remedies for South African consumers. The product portfolio spans multiple delivery formats — antibacterial throat lozenges, throat spray, cough and cold syrups, hot medicated drinks (Medsip), effervescent tablets, and throat gargle — each formulated with active ingredients such as Cetylpyridinium Chloride, Ivy Leaf, Pelargonium sidoides, Menthol, Paracetamol, and supporting vitamins to deliver targeted symptom relief.
Is Cepacol a public or private company?
Cepacol is a private company. It is classified as corporate owned and is currently operating.
When was Cepacol founded?
Cepacol was founded in -1. It employs 51 to 100 people.
Where is Cepacol based?
Cepacol is headquartered in Midrand, South Africa, in the Africa region.
How does Cepacol make money?
One revenue line is on record: OTC Pharmaceutical Product Sales.
Who are Cepacol's main competitors?
Direct peers on record are Difflam, Strepsils, Betadine, ACC, Prospan, Mucosolvan and Lemsip. Vicks is listed as a broad incumbent. Panado is listed as an others. Covonia is listed as a regional player.
Does Cepacol have an API?
No public API is recorded for Cepacol.
What industry is Cepacol in?
Cepacol's product category is OTC Pharmaceuticals (Throat Care & Cold/Flu Remedies). Its primary akta.pro industry code is HLAIADAB, Cold, Flu & Cough Remedies, with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 325412 and its SIC code is 2834.